Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EDIT – Editas Medicine, Inc.

Editas Medicine, Inc.
EDIT
$1.28
Name : Editas Medicine, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $107,148,160.00
EPSttm : -2.88
finviz dynamic chart for EDIT
Editas Medicine, Inc.
$1.28
0.79%
$0.01

Float Short %

15.3

Margin Of Safety %

Put/Call OI Ratio

0.1

EPS Next Q Diff

0.13

EPS Last/This Y

1.35

EPS This/Next Y

0.41

Price

1.28

Target Price

3.78

Analyst Recom

2.6

Performance Q

3.23

Relative Volume

0.2

Beta

2.08

Ticker: EDIT




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-20EDIT1.370.100.3444353
2025-03-21EDIT1.310.091.0544052
2025-03-24EDIT1.390.080.2135698
2025-03-25EDIT1.3050.090.2036320
2025-03-26EDIT1.2750.090.0836702
2025-03-27EDIT1.30.090.7436819
2025-03-28EDIT1.250.090.0137052
2025-03-31EDIT1.1650.090.2737027
2025-04-01EDIT1.130.090.0537370
2025-04-02EDIT1.190.090.2637766
2025-04-03EDIT1.120.090.6538270
2025-04-04EDIT1.030.091.1038660
2025-04-07EDIT1.0050.100.8839585
2025-04-08EDIT0.98160.100.1140067
2025-04-09EDIT1.160.100.3140482
2025-04-10EDIT1.110.100.0040706
2025-04-11EDIT1.290.090.1340946
2025-04-14EDIT1.320.100.0141202
2025-04-15EDIT1.360.090.5641160
2025-04-16EDIT1.2650.100.0741669
2025-04-17EDIT1.2850.100.0341845
2025-04-18EDIT1.280.100.0341845
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-20EDIT1.3722.5- -1.52
2025-03-21EDIT1.3022.5- -1.53
2025-03-24EDIT1.3923.0- -1.53
2025-03-25EDIT1.3023.0- -1.53
2025-03-26EDIT1.2723.0- -1.53
2025-03-27EDIT1.3023.0- -1.53
2025-03-28EDIT1.2523.0- -1.53
2025-03-31EDIT1.1623.0- -1.53
2025-04-01EDIT1.1323.0- -1.53
2025-04-02EDIT1.1823.0- -1.53
2025-04-03EDIT1.1223.0- -1.53
2025-04-04EDIT1.0423.0- -1.53
2025-04-07EDIT1.0223.0- -1.53
2025-04-08EDIT0.9823.0- -1.53
2025-04-09EDIT1.1523.0- -1.53
2025-04-10EDIT1.1123.0- -1.53
2025-04-11EDIT1.2923.0- -1.53
2025-04-14EDIT1.3223.0- -1.53
2025-04-15EDIT1.3523.0- -1.53
2025-04-16EDIT1.2623.0- -1.53
2025-04-17EDIT1.2823.0- -1.53
2025-04-18EDIT1.2823.0- -1.53
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-20EDIT-3.30-6.8816.74
2025-03-21EDIT-3.30-6.8816.74
2025-03-24EDIT-3.30-6.8516.74
2025-03-25EDIT-3.30-6.8516.74
2025-03-26EDIT-3.30-6.8515.99
2025-03-27EDIT-3.30-6.8515.99
2025-03-28EDIT-3.30-6.8515.99
2025-03-31EDIT-3.30-7.2915.99
2025-04-01EDIT-3.30-7.2915.99
2025-04-02EDIT-3.30-7.2915.99
2025-04-03EDIT-3.30-7.2915.99
2025-04-04EDIT-3.30-7.2915.99
2025-04-07EDIT-3.30-7.3815.99
2025-04-08EDIT-3.30-7.3815.99
2025-04-09EDIT-3.30-7.3815.99
2025-04-10EDIT-3.30-7.3815.43
2025-04-11EDIT-3.27-7.3815.29
2025-04-14EDIT-3.27-7.4215.30
2025-04-15EDIT-3.21-7.4215.30
2025-04-16EDIT-3.21-7.4215.30
2025-04-17EDIT-3.21-7.4215.30
2025-04-18EDIT-3.21-7.4215.30
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

-0.55

Avg. EPS Est. Current Quarter

-0.58

Avg. EPS Est. Next Quarter

-0.42

Insider Transactions

-3.21

Institutional Transactions

-7.42

Beta

2.08

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

1

Fair Value

Quality Score

14

Growth Score

32

Sentiment Score

68

Actual DrawDown %

98.7

Max Drawdown 5-Year %

-98.9

Target Price

3.78

P/E

Forward P/E

PEG

P/S

3.32

P/B

0.79

P/Free Cash Flow

EPS

-2.88

Average EPS Est. Cur. Y​

-1.53

EPS Next Y. (Est.)

-1.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-733.74

Relative Volume

0.2

Return on Equity vs Sector %

-196.6

Return on Equity vs Industry %

-183.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.08

EBIT Estimation

Editas Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 246
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
stock quote shares EDIT – Editas Medicine, Inc. Stock Price stock today
news today EDIT – Editas Medicine, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EDIT – Editas Medicine, Inc. yahoo finance google finance
stock history EDIT – Editas Medicine, Inc. invest stock market
stock prices EDIT premarket after hours
ticker EDIT fair value insiders trading